Literature DB >> 18721276

The T244I variant of the interleukin-7 receptor-alpha gene and multiple sclerosis.

A Alcina1, M Fedetz, D Ndagire, O Fernández, L Leyva, M Guerrero, C Arnal, C Delgado, F Matesanz.   

Abstract

Several but not all studies have provided evidence for the association between multiple sclerosis (MS) and the T244I variant of the interleukin-7 receptor-alpha gene (IL7RA), rs6897932. We performed a new replication case-control study in 599 MS patients and 594 healthy controls, all Caucasians from the south of Spain. The genotype and allele frequencies differed between MS cases and controls. The IL7RA rs6897932 C allele and the CC genotype were found to be factors for disease susceptibility [per allele odds ratio (OR) 1.32, 95% CI 1.1-1.6, P=0.0031; per CC genotype vs TT + TC genotypes, OR 1.5, 95% CI 1.18-1.87, P=0.0007]. The combined data analysis included 3324 cases and 5032 controls of Europeans and Americans of European origin resulting in stronger association with similar OR (P=1.9 x 10E-9). These findings in our sample support previous reported association studies between IL7RA rs6897932 and MS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18721276     DOI: 10.1111/j.1399-0039.2008.01075.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  8 in total

Review 1.  IL7RA genetic variants differentially affect IL-7Rα expression and alternative splicing: a role in autoimmune and infectious diseases?

Authors:  Christian Lundtoft; Julia Seyfarth; Marc Jacobsen
Journal:  Genes Immun       Date:  2020-01-13       Impact factor: 2.676

2.  Association between the IL7R T244I polymorphism and multiple sclerosis risk: a meta analysis.

Authors:  Song Wu; Qian Liu; Ji-Min Zhu; Ming-Rui Wang; Jing Li; Mei-Guo Sun
Journal:  Neurol Sci       Date:  2016-05-17       Impact factor: 3.307

3.  Association between the IL7R T244I polymorphism and multiple sclerosis: a meta-analysis.

Authors:  Ruijie Zhang; Lian Duan; Yongshuai Jiang; Xuehong Zhang; Peng Sun; Jin Li; Mingming Zhang; Guoping Tang; Xing Wang; Xia Li
Journal:  Mol Biol Rep       Date:  2010-12-16       Impact factor: 2.316

4.  Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis.

Authors:  Sergio E Baranzini; Joanne Wang; Rachel A Gibson; Nicholas Galwey; Yvonne Naegelin; Frederik Barkhof; Ernst-Wilhelm Radue; Raija L P Lindberg; Bernard M G Uitdehaag; Michael R Johnson; Aspasia Angelakopoulou; Leslie Hall; Jill C Richardson; Rab K Prinjha; Achim Gass; Jeroen J G Geurts; Jolijn Kragt; Madeleine Sombekke; Hugo Vrenken; Pamela Qualley; Robin R Lincoln; Refujia Gomez; Stacy J Caillier; Michaela F George; Hourieh Mousavi; Rosa Guerrero; Darin T Okuda; Bruce A C Cree; Ari J Green; Emmanuelle Waubant; Douglas S Goodin; Daniel Pelletier; Paul M Matthews; Stephen L Hauser; Ludwig Kappos; Chris H Polman; Jorge R Oksenberg
Journal:  Hum Mol Genet       Date:  2008-11-14       Impact factor: 6.150

5.  HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain).

Authors:  Oscar Fernández; Alfredo R-Antigüedad; María Jesús Pinto-Medel; Mari Mar Mendibe; Nestor Acosta; Begoña Oliver; Miguel Guerrero; Marcos Papais-Alvarenga; Victoria Fernández-Sánchez; Laura Leyva
Journal:  J Neurol       Date:  2009-12       Impact factor: 4.849

6.  The promoter SNP, but not the alternative splicing SNP, is linked to multiple sclerosis among Jordanian patients.

Authors:  Leena Ibayyan; Rand Zaza; Said Dahbour; Ammar El-Omar; Bilal Samhouri; Mohammad El-Khateeb; Mamoun Ahram
Journal:  J Mol Neurosci       Date:  2013-10-30       Impact factor: 3.444

7.  Assessment of IL-7RA T244I Polymorphism as a Risk Factor of Multiple Sclerosis in Turkish Population.

Authors:  Miraç Aysen Ünsal; Nüket Yıldız Manukyan; Nihal IŞik; Güher Saruhan Dİreskenelİ
Journal:  Noro Psikiyatr Ars       Date:  2019-08-26       Impact factor: 1.339

Review 8.  Soluble IL-7Rα/sCD127 in Health, Disease, and Its Potential Role as a Therapeutic Agent.

Authors:  Priscila O Barros; Tamara K Berthoud; Nawaf Aloufi; Jonathan B Angel
Journal:  Immunotargets Ther       Date:  2021-03-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.